• Newsletter
  • Search
  • Contacto
  • Home (next newsletter)
  • Home
  • News # 80 | Jun. 2018
  • News # 81 | Jul. 2018
  • News # 82 | Set. 2018
  • News # 83 | Oct. 2018
  • News # 84 | Nov. 2018
  • News # 85 | Dec. 2018
  • News # 86 | Jan. 2019
  • News # 87 | Feb. 2019
  • News # 88 | Mar. 2019
  • News # 89 | Apr. 2019
  • News # 90 | May. 2019
  • News # 91 | Jun. 2019
  • News # 92 | Jul. 2019
  • News # 93 | sep. 2019
  • Newsletters
    • 2008 – 2009
      • News # 1 | nov. 2008
      • News # 10 | nov/dez. 2009
      • News # 2 | dec. 2008
      • News # 3 | jan/fev. 2009
      • News # 4 | mar. 2009
      • News # 5 | abr. 2009
      • News # 6 | mai/jun. 2009
      • News # 7 | jul. 2009
      • News # 8 | ago/set. 2009
      • News # 9 | out. 2009
    • 2010 – 2011
      • News # 11 | jan/fev. 2010
      • News # 12 | mar. 2010
      • News # 13 | abr. 2010
      • News # 14 | mai. 2010
      • News # 15 | jun/jul. 2010
      • News # 16 | ago/set. 2010
      • News # 17 | out/nov. 2010
      • News # 18 | dez. 2010
      • News # 19 | jan/fev. 2011
      • News # 20 | mar/abr. 2011
      • News # 21 | mai/jun. 2011
      • News # 22 | jul/ago. 2011
      • News # 23 | set/out. 2011
      • News # 24 | nov/dez. 2011
    • 2012 – 2013
      • News # 25 | jan. 2012
      • News # 26 | fev/mar. 2012
      • News # 27 | jun. 2012
      • News # 28 | ago. 2012
      • News # 29 | set/out. 2012
      • News # 30 | nov/dez. 2012
      • News # 31 | jan. 2013
      • News # 32 | mar. 2013
      • News # 33 | abr. 2013
      • News # 34 | mai. 2013
      • News # 35 | jun. 2013
      • News # 36 | set. 2013
      •  News # 37 | out. 2013
      • News # 38 | nov/dez. 2013
    • 2014 – 2015
      • News # 39 | jan/fev. 2014
      • News # 40 | mar. 2014
      • News # 41 | abr/mai. 2014
      • News # 42 | jun/jul. 2014
      • News # 43 | set. 2014
      • News # 44 | out/nov. 2014
      • News # 45 | dez. 2014
      • News # 46 | jan. 2015
      • News # 47 | fev. 2015
      • News # 48 | abr. 2015
      • News # 49 | mai. 2015
      • News # 50 | jun. 2015
      • News # 51 | set. 2015
      • News # 52 | out. 2015
      • News # 53 | dez. 2015
    • 2016 – 2017
      • News # 54 | jan. 2016
      • News # 55 | fev. 2016
      • News # 56 | mar. 2016
      • News # 57 | abr. 2016
      • News nº 58 | may 2016
      • News # 59 | jun. 2016
      • News # 60 | jul. 2016
      • News # 61 | set. 2016
      • News # 62 | out. 2016
      • News # 63 | nov/dez. 2016
      • News # 64 | jan. 2017
      • News # 65 | fev. 2017
      • News # 66 | mar. 2017
      • News # 67 | apr. 2017
      • News # 68 | may 2017
      • News # 69 | jun. 2017
      • News # 70 | jul. 2017
      • News # 71 | set. 2017
      • News # 72 | out. 2017
      • News # 73 | nov. 2017
      • News # 74 | dez. 2017
    • 2018
      • News # 75 | jan. 2018
      • News # 76 | fev. 2018
      • News # 77 | mar. 2018
      • News # 78 | abr. 2018
      • News #79 | May 2018
  • Subscribe Newsletter
My Company
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto
Main Menu
  • Home
  • Newsletters
    • 2018 – 2019
      • News nº 92 | jul. 2019
      • News nº 91 | jun. 2019
      • News nº 90 | Mai. 2019
      • News nº 89 | Abr. 2019
      • News nº 88 | Mar. 2019
      • News nº 87 | Fev. 2019
      • News nº 86 | Jan. 2019
      • News nº 85 | Dez. 2018
      • News nº 84 | Nov. 2018
      • News nº 83 | Out. 2018
      • News nº 82 | Set. 2018
      • News nº 81 | Jul. 2018
      • News nº 80 | Jun. 2018
      • News Nº 79 | Mai. 2018
      • News nº 78 | abr. 2018
      • News nº 77 | mar. 2018
      • News nº 76 | fev. 2018
      • News nº 75 | jan. 2018
    • 2016 – 2017
      • News nº 74 | dez. 2017
      • News # 73 | nov. 2017
      • News # 72 | out. 2017
      • News # 70 | set. 2017
      • News nº 70 | jul. 2017
      • News nº 69 | jun. 2017
      • News nº 68 | mai. 2017
      • News nº 67 | abr. 2017
      • News nº 66 | mar. 2017
      • News nº 65 | fev. 2017
      • News nº 64 | jan. 2017
      • News nº 63 | nov/dez. 2016
      • News nº 62 | out. 2016
      • News nº 61 | set. 2016
      • News nº 60 | jul. 2016
      • News nº 59 | jun. 2016
      • News nº 58 | mai. 2016
      • News nº 57 | abr. 2016
      • News nº 56 | mar. 2016
      • News nº 55 | fev. 2016
      • News nº 54 | jan. 2016
    • 2014 – 2015
      • News nº 53 | dez. 2015
      • News nº 52 | out. 2015
      • News nº 51 | set. 2015
      • News nº 50 | jun. 2015
      • News nº 49 | mai. 2015
      • News nº 48 | abr. 2015
      • News nº 47 | fev. 2015
      • News nº 46 | jan. 2015
      • News nº 45 | dez. 2014
      • News nº 44 | out/nov. 2014
      • News nº 43 | set. 2014
      • News nº 42 | jun/jul. 2014
      • News nº 41 | abr/mai. 2014
      • News nº 40 | mar. 2014
      • News nº 39 | jan/fev. 2014
    • 2012 – 2013
      • News nº 38 | nov/dez. 2013
      • News nº 37 | out. 2013
      • News nº 36 | set. 2013
      • News nº 35 | jun. 2013
      • News nº 34 | mai. 2013
      • News nº 33 | abr. 2013
      • News nº 32 | mar. 2013
      • News nº 31 | jan. 2013
      • News nº 30 | nov/dez. 2012
      • News nº 29 | set/out. 2012
      • News nº 28 | ago. 2012
      • News nº 27 | jun. 2012
      • News nº 26 | fev/mar. 2012
      • News nº 25 | jan. 2012
    • 2010 – 2011
      • News nº 24 | nov/dez. 2011
      • News nº 23 | set/out. 2011
      • News nº 22 | jul/ago. 2011
      • News nº 21 | mai/jun. 2011
      • News nº 20 | mar/abr. 2011
      • News nº 19 | jan/fev. 2011
      • News nº 18 | dez. 2010
      • News nº 17 | out/nov. 2010
      • News nº 16 | ago/set. 2010
      • News nº 15 | jun/jul. 2010
      • News nº 14 | mai. 2010
      • News nº 13 | abr. 2010
      • News nº 12 | mar. 2010
      • News nº 11 | jan/fev. 2010
    • 2008 – 2009
      • News nº 10 | nov/dez. 2009
      • News nº 9 | out. 2009
      • News nº 8 | ago/set. 2009
      • News nº 7 | jul. 2009
      • News nº 6 | mai/jun. 2009
      • News nº 5 | abr. 2009
      • News nº 4 | mar. 2009
      • News nº 3 | jan/fev. 2009
      • News nº 2 | dez. 2008
      • News nº 1 | nov. 2008
  • Subscrever Newsletter
  • Contacto

A quantum leap

By etavares On 31 October, 2016 2016 | Moments Comments Off on A quantum leap No tags

It was 1998. I had prepared for my aggregation exams a proposal for a new optional subject in Molecular Medicine to include in year six of the Medical Degree. I believed that once in possession of clinical training, the student-doctor would be well prepared to absorb the impact of the “new biology” in his clinical practice and thus put it at the service of the patients.

To my chagrin, the proposal did not to merit more than vague circumstantial compliments by the panel, chaired by João Lobo Antunes, so I immediately foresaw that it was destined to oblivion in some obscure file in the depths of the house.

What I could never have predicted was what ensued. As usual, João Lobo Antunes had read the course report carefully, particularly the laborious argument in its favour, contained in the introduction. Horrified for having stumbled somewhere across the detested word “holistic” (I confess that I never used it since), he showed no enthusiasm for the hypothetical new subject. He just told me that the important thing was not to teach what soon would be forgotten, the important thing was, rather, to create the conditions so that molecular medicine was practiced in a sustainable manner, at the highest level, in the School itself. He said that creating an “Institute of Molecular Medicine” at the Faculty was what had to be done.

I remember the astonishment I felt at the time. It was like witnessing a quantum leap, a phenomenon I thought was invisible and reserved to the realm of the theoretical abstraction of physics. And yet it was, by representing an abrupt discontinuity of “energy states”.

He immediately created a small group to advance the matter. Initially we were three, Rui Victorino, Domingos Henrique and myself, later joined by Carmo Fonseca. It was an interesting and intense time of comprehensive analysis of similar international models, conversations with colleagues from other countries who had long lived similar experiences, of meetings he conducted with his admirable and unforgiving lucidity.

However, there were two problems that had to be solved first. The first was, of course, to create the operational conditions that would enable such an institute. At the time, the only way to do it was to get access to the exclusive club of Laboratories Associated with the Ministry of Science, which were structures with privileged public funding, meta-university entities with agile management rules, free from the bureaucratic corset of the University. The Associated Laboratories, however, could only see the light of day based on the ministry’s sole discretion, which was why I was in charge of “probing the FCT on the subject. I did probe, and Luis Magalhães, at the time the President of the FCT, immediately showed what is now customary known as “openness”. Yes, the Ministry would welcome a new Biomedical Associate Laboratory in Lisbon, based on the “CEBIP”, an FCT centre created years earlier by David-Ferreira.

A second problem still needed to be addressed:  to convince the school to welcome, without rejecting it, a “foreign body” attached to it, but independent from it. Lobo Antunes, a negotiator as skilled as pragmatic, knew well what to expect. But he knew also that freedom, coupled with an uncompromising qualitative requirement, are the values that support good science and, therefore, are not negotiable.

And he made it! In 2002, the Institute of Molecular Medicine was formally established as an Associate Laboratory and occupied the (little) space remaining in the new Egas Moniz building, already (generously) occupied by some basic sciences institutes of the faculty.

Under his strategic direction, as President, assisted by the strong and effective hand of the Executive Director Maria do Carmo Fonseca, the Institute of Molecular Medicine has quickly become a bustling environment of young researchers, some of them coming from international paths of excellence.

Ten years later, when he decided to pass the baton to Carmo Fonseca and assign the new Executive Directorate to Maria Mota, Bruno Silva Santos and Henrique Veiga Fernandes, themselves young rising stars in the science world, the Institute of Molecular Medicine was already considered to be one of the best biomedical research centres in the country.

I say “considered” because, as we know, in science what matters is not the subjective and “local” perception of value. The absolute and relative value of an institution may only be determined by external evaluation, which is free and competitive. Thus, consideration would only become an unquestionable fact when, in 2014, the IMM was recognized as excellent by independent international evaluators, under a comprehensive assessment of all R&D l units in the country.

What this evaluation could not show, however, was the impact of the institution on the University itself. In October 2015, when I was still in government functions, Maria Mota invited me to say “a few words” at  a public presentation ceremony of an ERA-CHAIR of the IMM (CAML).

I asked to be given disaggregated statistical data on the University of Lisbon, concerning the capture of funds as part of Horizon 2020, the most competitive European programme for science funding. I confess to my surprise (and that of all) that 45% of around EUR 33 million from the University of Lisbon in the first two years of that programme (2014 and 2015) had been obtained by the Institute of Molecular Medicine.

What was the reason for this unique success? The international competitiveness in science is obviously a proxy of quality, and the quality, in turn, always derives from the activity of individuals. I looked for it, and the explanation came, cut and clear: The Institute of Molecular Medicine was, at the time, the public research centre with more grantees of the European Research Council, and one of the institutions with the highest number of FCT Researchers, themselves selected by competitive international tender. The Institute of Molecular Medicine had become unequivocally a talent attractor pole.

These figures tell us little, however, about the immateriality of the influence of the Institute on the actual Faculty of Medicine. I have no data that allow me to have an objective judgment. I only know that the Institute of Molecular Medicine is now a source of pride for the Faculty, and that several of its lecturers are leading researchers, that students enjoy contact with laboratories and scientists, and that clinical research gradually acquires the strength derived from multidisciplinary research. For its part, the Hospital, a key element of the CAML trinity, systematically invokes the “partnership” with the IMM as the distinctive curricular component of the national hospital centres.

My perception, as an external observer who does not belong to the IMM, is to look at the way you have trodden (and when you look back you see that you will never tread on that path again), and realize that Lobo Antunes’ biggest aim – the fruitful and harmonious cooperation between basic science and clinical medicine, based on impeccable ethical values and institutional ethos – has not yet been fully achieved.

This is the challenge, and the moral imperative, of the current leaders in the years to come.

Is it an easy task with guaranteed success? Certainly not and he knew it better than anyone. But as Edward O. Wilson in his bright book Consilience. The Unity of Knowledge says, “The moral imperative of humanism is the endeavour alone, whether successful or not, provided the effort is honourable and memorable failure. If those committed to the quest fail, they will be forgiven. When lost, they will find another way”.

 

Leonor Parreira

Lisboa, 30 October 2016

Share

Search

Index – News # 62 | out. 2016
 Renewal
 Presentation of the Chemistry College of the ULisboa
 The Multidisciplinary Advanced Simulation Centre will open in 2017
 Opening of the Academic Year 2016-2017
 Inauguration of the first Master Degree in Hyperbaric and Underwater Medicine in Portugal
 European Researchers’ Night
 2nd Session II of the Graduate Students’ Integration Committee
 Last Lesson of Professor Daniel Sampaio – 26 October 2016
 Last Lesson of Professor Luís Mendes Graça – 19 September 2016
 New Kaleidoscope of the University of Lisbon
 Scientific publications (FMUL/HSM/IMM) – October 2016
 Educational Cooperation Agreement between FMUL and DCBM UALG
 October News
 The Wisdom of the Tribe – To João Lobo Antunes in memoriam
 In Memoriam
 A quantum leap
 Manuel de Mello Scholarship
 Basic Course in Geriatrics
 Third Edition of the Education and Medical Education Day
 15th Edition “Hospital of the Little Ones” – 21 and 25 November
 FCT informs that in the weeks 3-17 October announced the opening of the following contests for scholarships and awards:
 Cooking and Healthy Eating Day
 2nd Annual Meeting of Doctoral Students | Mind-Brain Doctoral College of ULisboa – 28 and 29 November
 Junior Doctors International Meeting | 11 to 13 november
 OBITUARY | Death of Professor António Baptista Fernandes
 Death of Professor João Lobo Antunes
My Company

100 AnosPropriedade e Edição: Faculdade de Medicina da Universidade de Lisboa NIPC: 502662875  Periodicidade: Mensal  Diretor: Prof. Doutor Fausto J. Pinto Conselho Editorial: Prof. Doutor Fausto J. Pinto, Profª. Doutora Ana Sebastião, Prof. Doutor Mamede de Carvalho, Prof. Doutor António Vaz Carneiro, Prof. Doutor Miguel Castanho, Dr. Luís Pereira  Equipa Editorial:  Ana Raquel Moreira, Cristina Bastos, Isabel Varela, Joana Sousa, Maria de Lurdes Barata, Rui Gomes, Sónia Teixeira  Colaboração:  Gabinete de Relações Públicas, Internacionais e Comunicação  Versão Inglesa: AP|PORTUGAL- Language Services  Conceção: Metatexto, Lda. e-mail: news@medicina.ulisboa.pt  Sede do Editor e Sede da Redação: Avenida Prof. Egas Moniz, 1649-028 Lisboa Estatuto Editorial Anotado na ERC 

  • Increase Font
  • Decrease Font
  • Black & White
  • Inverse Colors
  • Highlight Links
  • Regular Font
  • Reset
Real Accessability